Zogenix’s Fintepla Reduces Drop Seizure Rates, But Is It Enough?

 
• By Mandy Jackson
  
Red dart arrow hitting in the target center of dartboard with modern city and sunset background. Target business, achieve and victory concept .
Fintepla reduced monthly drop seizures in Lennox-Gastaut syndrome
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D